Ascendis Pharma A (ASND) Change in Inventory (2021 - 2026)
Ascendis Pharma A (ASND) posted Change in Inventory of -$15.0 million for Q1 2026, down 2672.21% sequentially from $583185.8 in Q4 2025, and down 661.89% YoY from $2.7 million in Q1 2025.
Ascendis Pharma A (ASND) Change in Inventory (2021 - 2026) Analysis & Trends
Ascendis Pharma A has reported Change in Inventory for 6 years, with the latest figure at -$15.0 million in Q1 2026.
- Quarterly Change in Inventory fell 661.89% year-over-year to -$15.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$24.5 million (up 62.38% YoY) and the FY2025 annual result came in at -$6.9 million, up 92.56% from the prior year.
- Change in Inventory eased to -$15.0 million in Q1 2026 per ASND's latest filing, from $583185.8 in the prior quarter.
- Over five years, Change in Inventory peaked at $2.7 million in Q1 2025 and troughed at -$32.2 million in Q4 2024.
- A 5-year average of -$15.2 million and a median of -$18.6 million in 2023 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2023 and 2025: Change in Inventory tumbled 762.95% in 2023, then soared 110.35% in 2025.
- Over 5 years, Change in Inventory stood at -$27.2 million in 2022, then climbed by 21.79% to -$21.3 million in 2023, then slumped by 51.37% to -$32.2 million in 2024, then soared by 101.81% to $583185.8 in 2025, then tumbled by 2672.21% to -$15.0 million in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered -$15.0 million, $583185.8, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Ascendis Pharma A | 15.40 Bn | 14.73 Bn | 268.20 Mn | -15.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.00 Mn |
| Mar 31, 2026 | -15.00 Mn |
| Dec 31, 2025 | 583,185.80 |
| Dec 31, 2025 | 583,185.80 |
| Sep 30, 2025 | 1.58 Mn |
| Sep 30, 2025 | 1.58 Mn |
| Jun 30, 2025 | -11.67 Mn |
| Jun 30, 2025 | -11.67 Mn |
| Mar 31, 2025 | 2.67 Mn |
| Mar 31, 2025 | 2.67 Mn |
| Dec 31, 2024 | -32.25 Mn |
| Dec 31, 2024 | -32.25 Mn |
| Sep 30, 2024 | -15.63 Mn |
| Sep 30, 2024 | -15.63 Mn |
| Jun 30, 2024 | -19.94 Mn |
| Jun 30, 2024 | -19.94 Mn |
| Mar 31, 2024 | -25.80 Mn |
| Mar 31, 2024 | -25.80 Mn |
| Dec 31, 2023 | -21.30 Mn |
| Dec 31, 2023 | -21.30 Mn |